Searched for
LAPATINIB
Hetero launches generic breast cancer treatment drug in IndiaDrug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in th...- The pill that costs $9,000 in US sells for $70 in IndiaAnd that's just one leukaemia drug. India's generic industry has been producing many such life-saving medicines at a fraction of the global...
- The pill that costs $9,000 in US sells for $70 in IndiaTypically, the price of many expensive patented drugs in European countries like France, Spain or the UK is half of what these cost in the ...
- MNCs deprive India of vital drugs despite getting monopoly rightsJapanese firm Otsuka Pharmaceuticals, Myers-Squibb, Novartis are deferring launch of medicines critical for treatment of serious non-commun...
- Government panel moots clinical trial waiver for two cancer drugsThe two medicines - Aflibercept and Trastuzumab emtansine - are used in treatment of metastatic colorectal cancer and metastatic breast can...
- Lupin, Natco tie up to market breast cancer tabletsDrug firms Lupin Ltd and Natco Pharma today said that they have entered into an alliance to jointly market generic Lapatinib Ditosylate tab...
- Cipla opposes patent for GSK’s cancer drugCipla has filed a grant opposition in the Kolkata patent office against GSK's newly-launched breast cancer drug on grounds of obviousness a...
- Global pharma cos to reduce pill prices in IndiaGlobal pharmaceutical companies are launching their medicines in India at up to one-fifth of their global prices. World News and Trends
Load More